251 related articles for article (PubMed ID: 22500177)
21. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.
Yap DYH; Chan TM
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835612
[TBL] [Abstract][Full Text] [Related]
22. Systemic lupus erythematosus and ocular involvement: an overview.
Dammacco R
Clin Exp Med; 2018 May; 18(2):135-149. PubMed ID: 29243035
[TBL] [Abstract][Full Text] [Related]
23. What's New in the Treatment of Systemic Lupus Erythematosus.
Liossis SN; Staveri C
Front Med (Lausanne); 2021; 8():655100. PubMed ID: 33748165
[TBL] [Abstract][Full Text] [Related]
24. Systemic lupus Erythematosus activity and Hydroxychloroquine use before and after end-stage renal disease.
Salgado Guerrero M; Londono Jimenez A; Dobrowolski C; Mowrey WB; Goilav B; Wang S; Broder A
BMC Nephrol; 2020 Oct; 21(1):450. PubMed ID: 33115441
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus.
Thorbinson C; Oni L; Smith E; Midgley A; Beresford MW
Paediatr Drugs; 2016 Jun; 18(3):181-95. PubMed ID: 26971103
[TBL] [Abstract][Full Text] [Related]
26. [Unmet needs in systemic lupus erythematosus].
Ichinose K
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):396-407. PubMed ID: 29367524
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic potential of IL-27 in systemic lupus erythematosus.
Pan HF; Tao JH; Ye DQ
Expert Opin Ther Targets; 2010 May; 14(5):479-84. PubMed ID: 20350048
[TBL] [Abstract][Full Text] [Related]
28. Rowell Syndrome in Nigeria: Systemic Lupus Erythematosus Presenting as Recurrent Erythema Multiforme in a Young Woman.
Akintayo RO; Olarinoye GM; Akintayo FC; Ilesanmi ON
Acta Dermatovenerol Croat; 2019 Sep; 27(3):200-201. PubMed ID: 31542069
[TBL] [Abstract][Full Text] [Related]
29. Systemic lupus erythematosus.
Shaikh MF; Jordan N; D'Cruz DP
Clin Med (Lond); 2017 Feb; 17(1):78-83. PubMed ID: 28148586
[TBL] [Abstract][Full Text] [Related]
30. Natural products action on pathogenic cues in autoimmunity: Efficacy in systemic lupus erythematosus and rheumatoid arthritis as compared to classical treatments.
Cao F; Cheng MH; Hu LQ; Shen HH; Tao JH; Li XM; Pan HF; Gao J
Pharmacol Res; 2020 Oct; 160():105054. PubMed ID: 32645358
[TBL] [Abstract][Full Text] [Related]
31. Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives.
Magro-Checa C; Zirkzee EJ; Huizinga TW; Steup-Beekman GM
Drugs; 2016 Mar; 76(4):459-83. PubMed ID: 26809245
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
Ruiz-Irastorza G; Danza A; Khamashta M
Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
[TBL] [Abstract][Full Text] [Related]
33. Why targeted therapies are necessary for systemic lupus erythematosus.
Durcan L; Petri M
Lupus; 2016 Sep; 25(10):1070-9. PubMed ID: 27497251
[TBL] [Abstract][Full Text] [Related]
34. Childhood Systemic Lupus Erythematosus; a Rare Multisystem Disorder: Case Report of a 3-year-old Girl with Oral Involvement as a Primary Sign.
Horri A; Danesh M; Sadat Hashemipour M
J Dent (Shiraz); 2020 Dec; 21(4):338-342. PubMed ID: 33344686
[TBL] [Abstract][Full Text] [Related]
35. Biological and targeted therapies of systemic lupus erythematosus: evidence and the state of the art.
Mok CC
Expert Rev Clin Immunol; 2017 Jul; 13(7):677-692. PubMed ID: 28443384
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal system involvement in systemic lupus erythematosus.
Li Z; Xu D; Wang Z; Wang Y; Zhang S; Li M; Zeng X
Lupus; 2017 Oct; 26(11):1127-1138. PubMed ID: 28523968
[TBL] [Abstract][Full Text] [Related]
37. Ocular involvement in systemic lupus erythematosus.
Preble JM; Silpa-archa S; Foster CS
Curr Opin Ophthalmol; 2015 Nov; 26(6):540-5. PubMed ID: 26367085
[TBL] [Abstract][Full Text] [Related]
38. Emerging therapies in systemic lupus erythematous: from clinical trial to the real life.
Zhang H; Chambers W; Sciascia S; Cuadrado MJ
Expert Rev Clin Pharmacol; 2016; 9(5):681-94. PubMed ID: 26907827
[TBL] [Abstract][Full Text] [Related]
39. Respiratory Manifestations in Systemic Lupus Erythematosus.
Di Bartolomeo S; Alunno A; Carubbi F
Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33803847
[TBL] [Abstract][Full Text] [Related]
40. The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry.
Goulielmos GN; Zervou MI; Vazgiourakis VM; Ghodke-Puranik Y; Garyfallos A; Niewold TB
Gene; 2018 Aug; 668():59-72. PubMed ID: 29775752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
